Nuclear medicine diagnostics in neurooncology

被引：0
|
作者：
Langen, K. -J. [1 ]
Weckesser, M. [2 ]
Pauleit, D. [1 ]
Steiger, J. [3 ]
机构：
[1] Forschungszentrum Julich, Inst Neurowissensch & Med, D-52425 Julich, Germany
[2] Univ Munster, Nukl Med Klin & Poliklin, D-4400 Munster, Germany
[3] Univ Klinikums Dusseldorf, Neurochirurg Klin, Dusseldorf, Germany
来源：
NERVENHEILKUNDE | 2009年 / 28卷 / 10期
关键词：
Refractory PET; SPECT; brain tumors; POSITRON-EMISSION-TOMOGRAPHY; LOW-GRADE GLIOMAS; RADIOLABELED AMINO-ACIDS; PRIMARY BRAIN-TUMORS; CLINICAL-APPLICATIONS; CEREBRAL GLIOMAS; TL-201; SPECT; DIFFERENTIAL-DIAGNOSIS; C-11-METHIONINE PET; MALIGNANT GLIOMAS;
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
The diagnostic assessment of tumor extent, grading and detection of recurrence of brain tumors remains a challenge in the era of magnetic resonance imaging (MRI). Positron emission tomography (PET) and single photon emission computed tomography (SPECT) may provide relevant additional information which allow more accurate diagnostics in unclear situations. Especially, PET and SPECT studies using radiolabeled amino acids offer a better delineation of cerebral gliomas which helps to guide biopsies, to plan surgical interventions and radiation therapy. Additionally, several radiotracers help to differentiate tumor recurrence from unspecific post-therapeutic changes in brain tissue and provide information on histological grading and prognosis of brain tumors.
引用
收藏
页码：683 / 688
页数：6
相关论文
共 50 条
  • [41] Nuclear diagnostics of ICF
    Izumi, N
    Lerche, RA
    Moran, MJ
    Phillips, TW
    Sangster, TC
    Schmid, GJ
    Stoyer, MA
    Disdier, L
    Bourgade, JL
    Rouyer, A
    Fisher, RK
    Berggren, RR
    Caldwell, SE
    Faulkner, JR
    Mack, JM
    Oertel, JA
    Young, CS
    Glebov, VY
    Jaanimagi, PA
    Meyerhofer, DD
    Soures, JM
    Stoeckl, C
    Frenje, JA
    Li, CK
    Petrasso, RD
    ADVANCED DIAGNOSTICS FOR MAGNETIC AND INERTIAL FUSION, 2002, : 99 - 106
  • [42] ADVANCES IN NEUROONCOLOGY
    COAKHAM, H
    BRITISH JOURNAL OF CANCER, 1987, 56 (04) : 517 - 517
  • [43] Neurooncology News
    Uhl, M.
    Hau, P.
    AKTUELLE NEUROLOGIE, 2013, 40 (04) : 180 - 184
  • [44] Imaging in neurooncology
    Jacobs, A. H.
    Kracht, L. W.
    Thiel, A.
    Herholz, K.
    Heiss, W-D.
    EUROPEAN JOURNAL OF NEUROLOGY, 2006, 13 : 7 - 7
  • [45] Surgical neurooncology
    Tonn, JC
    NERVENHEILKUNDE, 2005, 24 (10) : 903 - 907
  • [46] Imaging in neurooncology
    Jacobs A.H.
    Kracht L.W.
    Gossmann A.
    Rüger M.A.
    Thomas A.V.
    Thiel A.
    Herholz K.
    NeuroRX, 2005, 2 (2): : 333 - 347
  • [47] Parameters for evaluating nuclear medicine and nuclear medicine
    Schober, O
    NUKLEARMEDIZIN, 1997, 36 (04) : A4 - A4
  • [48] From Nuclear Medicine to Nuclear Medicine Theranostics
    Dong Soo Lee
    Nuclear Medicine and Molecular Imaging, 2015, 49 (2) : 83 - 84
  • [49] From Nuclear Medicine to Nuclear Medicine Theranostics
    Lee, Dong Soo
    NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2015, 49 (02) : 83 - 84
  • [50] Update in neurooncology
    Schlegel, U.
    NERVENHEILKUNDE, 2010, 29 (11) : 747 - 752
12345